This initiative has created new capability and capacity in biological engineering in the UK and by maximising the amount of resource available, Loughborough is able to compete with the best in the world.

The 650m2 facility is made-up of a suite of Class 2 laboratories for microbial, animal and human cell growth, a bioelectrical facility and an analytical suite to service all laboratories. In particular the facility is entered via a dedicated restricted access laboratory transfer area, which will enable controlled operation for the whole area.

A second self-contained suite is dedicated to cGMP operation. Equipment available includes a range of new cell culture vessels, an automated cell culture platform, FACS, as well as other state-of-the art imaging and analytical techniques. Additionally, open plan postgraduate/postdoctoral writing and meeting rooms are located adjacent to these laboratories.

The activities within the CBE are positioned in the translational space between scientific discovery and the production of cell based/biological products, techniques and therapies. This makes us one of the major national centres for late stage, cGMP, process-oriented research.<br/><br/>The CBE is also home to the £5M Loughborough led and integrated Grand Challenge in Regenerative Medicine (remedi) and the £6.1m EPSRC Centre for Doctoral Training in Regenerative Medicine, which will fund the training of 50 PhD students over 5 years. The CDT is held jointly with Keele and Nottingham Universities, but is led from Loughborough.